Back
Vanguard Total Stock Market Index Fund ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
71
VTI
Vanguard Total Stock Market Index Fund ETF
Last Price:
$306.97
Seasonality Move:
0.15%
Sell
43
SRPT
Sarepta Therapeutics
Last Price:
$18.30
Seasonality Move:
20.21%
Buy
71
Vanguard Total Stock Market Index Fund ETF (VTI)
is a Buy
Is Vanguard Total Stock Market Index Fund ETF a Buy, Sell or Hold?
-
The current Vanguard Total Stock Market Index Fund ETF [VTI] share price is $305.51. The Score for VTI is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
VTI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $18.20. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VTI Stock Price Chart
What is Vanguard Total Stock Market Index Fund ETF's stock price today?
-
The Vanguard Total Stock Market Index Fund ETF share price today is $305.51Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTI is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $18.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
VTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.4 | Buy |
| Relative Strength Index (14 RSI): | 72.23 | Buy |
| Chaikin Money Flow: | 4258999 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (291.62 - 300.78) | Buy |
| Bollinger Bands (100): | (269.79 - 298.29) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.63 | Sell |
| Relative Strength Index (14 RSI): | 22.9 | Sell |
| Chaikin Money Flow: | 2644712 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.11 - 39.13) | Sell |
| Bollinger Bands (100): | (31.38 - 92.06) | Sell |
VTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 301.74 | Buy |
| 20-day SMA: | 297.56 | Buy |
| 50-day SMA: | 288.1 | Buy |
| 200-day SMA: | 287.5 | Buy |
| 8-day EMA: | 301.98 | Buy |
| 20-day EMA: | 297.82 | Buy |
| 50-day EMA: | 290.9 | Buy |
| 200-day EMA: | 282.8 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.83 | Buy |
| 20-day SMA: | 26.89 | Sell |
| 50-day SMA: | 38.26 | Sell |
| 200-day SMA: | 91.97 | Sell |
| 8-day EMA: | 18.98 | Sell |
| 20-day EMA: | 24.85 | Sell |
| 50-day EMA: | 37.93 | Sell |
| 200-day EMA: | 79.67 | Sell |
Vanguard Total Stock Market Index Fund ETF Earnings Growth & VTI Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.75 per share, a decrease this year of $5.88 per share, and an increase next year of $5.33 per share.
Vanguard Total Stock Market Index Fund ETF Technical Analysis
| Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||